EUVIMEDOpdag EUVIMED
Crossref

Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?

Rachita S Dhurat, Richa Sharma, Archi Ranka, Grishma Kale

Cosmoderma · 2026-07-18 · 6 · 86

DOI: 10.25259/csdm_94_2026 ↗

At a glance

Journal article in Cosmoderma, published online on 2026-07-18. Written by Rachita S Dhurat and 3 co-authors. 5 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Cite

APA

Dhurat, R. S., Sharma, R., Ranka, A., & Kale, G. (2026). Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?. Cosmoderma, 6, 86. https://doi.org/10.25259/csdm_94_2026

Vancouver

Dhurat RS, Sharma R, Ranka A, Kale G. Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?. Cosmoderma. 2026;6:86. doi:10.25259/csdm_94_2026

BibTeX
@article{Dhurat2026,
  author = {Dhurat, Rachita S and Sharma, Richa and Ranka, Archi and Kale, Grishma},
  title = {Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?},
  journal = {Cosmoderma},
  year = {2026},
  volume = {6},
  pages = {86},
  doi = {10.25259/csdm_94_2026}
}
Start for free →